NCT05096130

Brief Summary

Sleep has a number of health benefits, including memory and learning, vitality and energy as well as high quality of life levels. Lack of sleep impairs judgment, impacts longevity and safety, and increases the risk of a number of diseases including obesity, hypertension, heart disease, diabetes, mood disorders, and impaired immune function. In addition lack of sleep or disturbance of normal sleep cycle could have a major impact on people's lives and working performance such as driving. Daily sleepiness is a problem concerning professions with a non-fixed schedule. Specifically, professional long-haul drivers confront sleepiness problems and in combination with fatigue, they are prone to driving accidents and other incidents. Sleep quality and quantity are closed related to fatigue which is one of the most common reasons for driving and working accidents. In recent years, car accidents involving professional drives have increased significantly. The main reasons for those accidents were fatigue and sleepiness due to long hours of driving or difficult working conditions according to the recent European report (Driver Fatigue in European Road Transport - etf-europe.org). Lifestyle Medicine addresses health risk factors in primary, secondary, and tertiary prevention of developing disease rather than on acute care and reacting to illness, injury, and disease. Lifestyle Medicine strategies targeting modifiable risk factors, such as diet, sleep, stress, and physical activity. By applying those regimes the investigators could improve physical and mental health levels that can affect the quality of sleep, reducing daily sleepiness and fatigue, in professional drivers operating coaches and trucks. Any intervention that could improve alertness and reduce fatigue and sleepiness in those people, will automatically improve safety, reduce driving accidents and save lives and resources.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

September 30, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

October 27, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
Last Updated

June 5, 2023

Status Verified

June 1, 2023

Enrollment Period

1.3 years

First QC Date

September 30, 2021

Last Update Submit

June 2, 2023

Conditions

Keywords

drivinglifestyle medicineQuality of lifePhysical ActivityDietstresssleep coachingroad accidents

Outcome Measures

Primary Outcomes (3)

  • Changes in Daily Sleepiness

    The levels of daily sleepiness will be assessed by a Multiple Sleep Latency Test (MSLT). This is the gold standard approach for assessing daily sleepiness.

    Assessed at 0-month (pre) and at 6-month (post)

  • Changes in Levels fo Fatigue

    The levels of fatigue will be assessed by the FSS test

    Assessed at 0-month (pre) and at 6-month (post)

  • Changes in Quality of Sleep

    Quality of sleep will be assessed by a full night polysomnography study

    Assessed at 0-month (pre) and at 6-month (post)

Secondary Outcomes (4)

  • Changes in Body composition

    Assessed at 0-month (pre) and at 6-month (post)

  • Changes in Exercise Capacity

    Assessed at 0-month (pre) and at 6-month (post)

  • Changes in Stress levels Work Stress Questionnaire

    Assessed at 0-month (pre) and at 6-month (post)

  • Changes in Quality of Life levels

    Assessed at 0-month (pre) and at 6-month (post)

Study Arms (2)

Control Group - No intervention

NO INTERVENTION

The control group will not participate in any intervention for the duration of the study. In addition, the participants will be instructed to follow their usual daily schedule for 6 months. Changes in health, medication, or habits will be discussed by the investigators' team and reassess the continuation or the termination of the investigated participant.

Lifestyle Medicine Strategies Groupo

EXPERIMENTAL

The LSM (LifeStyle Medicine) group, will receive a 6-month lifestyle change intervention targeting the correction of diet, improving physical activity and exercise levels, reducing stress levels, and improving sleep hygiene by LSM registered professionals.

Behavioral: Lifestyle Medicine Strategies

Interventions

LM addresses health risk factors in primary, secondary, and tertiary prevention of developing disease rather than limiting resources and medical expenditures on acute care and reacting to illness, injury, and disease. The intervention will target the four pillars of the LM approach including physical activity, diet, stress, and sleep. Certified in LM strategies professionals will consult participants from the LM group in a biweekly base in order to improve their lifestyle habits.

Lifestyle Medicine Strategies Groupo

Eligibility Criteria

Age25 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • both sexes,
  • age between 25 and 60 yrs old
  • valid 5th category driving license for large trucks and coaches
  • minimum of 3 years of continuous and verifiable documented work experience as a professional driver in the past 5 years
  • diagnosed with moderate daily sleepiness as this is documented by a value \>9 in Epworth Sleepiness Scale (SSC)

You may not qualify if:

  • drivers with a driving license that expires within a year of the recruitment date,
  • disabilities that prevent them from walking independently or exercising,
  • verified mental illnesses,
  • alcoholism or drug abuses,
  • or conditions that could affect the outcome of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lifestlye Medicine Laboratory, TEFAA, University of Thessaly

Trikala, Thessaly, 42100, Greece

Location

MeSH Terms

Conditions

Disorders of Excessive SomnolenceFatigueSleep Disorders, Circadian RhythmMotor Activity

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersSigns and SymptomsPathological Conditions, Signs and SymptomsChronobiology DisordersOccupational DiseasesBehavior

Study Officials

  • Giorgos K Sakkas, PhD

    University of Thessaly

    PRINCIPAL INVESTIGATOR
  • Efthmios Dardiotis, MD, PhD

    University of Thessaly

    STUDY CHAIR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Parameters such as questionnaires' scores, polysomnography outcomes, indices of health, and other data will be masked and coded for blind analysis by the main investigator.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a randomized controlled trial. The study is composed of two groups. Group 1 is the control group and Group 2 is the experimental one. The trial period will last for 6 months for both groups. Intervention includes lifestyle changes targeting physical activity, diet, stress and sleep quality. The design is parallel.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ass Professor

Study Record Dates

First Submitted

September 30, 2021

First Posted

October 27, 2021

Study Start

September 1, 2021

Primary Completion

January 1, 2023

Study Completion

January 31, 2023

Last Updated

June 5, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations